The clinical impact may be significant, as nearly 50% of pediatric AML can be assigned to molecular categories characterized by HOX gene deregulation, including many high-risk categories.
← all excerpts
Novel classification system and high-risk categories of pediatric acute myeloid leukemia.
1
—
—